Medicine firms keep FTSE alive

clock

It's the turn of the pharmaceutical and medical firms to take a hit on the FTSE 100, as GlaxoSMithKline, Smith & Nephew and Alliance Unichem suffered falls by close of business in London.

The FTSE 100 index sustained the losses relatively well – partly because the markets had managed to stay afloat for most of the day – and closed up just 1.8 points at 4,571.8 as GSK ended down 21p or 1.79% to £11.51 and Smith & Nephew, seller of orthopedic devices, dropped 7.5p or 126% to 588p. Alliance Unichem eventually ended the day off 6.5p or 1.06% to 606p. Other stocks to make an impact included BAE Systems which gained 5p or 2.32% to 220.5p while publishing firm EMAP gained 25p or 2.89% to 899p. Xstrata, the mining company, also closed the day up 12p or 1.77% to 689p. In the...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Trian and General Catalyst to purchase Janus Henderson for $7.4bn

Trian and General Catalyst to purchase Janus Henderson for $7.4bn

Will continue to be led by current management team

Patrick Brusnahan
clock 23 December 2025 • 2 min read
2025 reflections: How strong companies trumped politics

2025 reflections: How strong companies trumped politics

Fears of an AI market bubble persist

Ryan Hughes
clock 23 December 2025 • 3 min read
What does 2026 hold for investment?

What does 2026 hold for investment?

‘The disruptors of yesterday are now the establishment’

Jen Frost
clock 17 December 2025 • 3 min read